HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.
about
HLA-G Molecules in Autoimmune Diseases and InfectionsSome basic aspects of HLA-G biologyImmunomodulatory properties of HLA-G in infectious diseasesHLA-dependent tumour development: a role for tumour associate macrophages?Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replicationHLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G.The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.HLA-G dimers in the prolongation of kidney allograft survival.Shaping of NK cell responses by the tumor microenvironmentRegulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.
P2860
Q26825516-7A650370-0418-417E-9ACD-F159EB93C859Q26852671-9C529D54-DE43-4EAA-A79F-E6782F89AF00Q27013645-50BBC8C7-F0FA-4DB9-B093-2220425CBF11Q27022124-A6A207E0-453A-4961-9EE7-16DFD014344EQ30354127-9B739036-D1E6-4229-9FE8-371596782C3AQ34038019-825D8E53-A426-458A-BE72-4D4319247985Q34261979-DC3F17FE-DF33-4159-B8CB-325500F97C22Q35077614-FAE1F127-5A14-48A0-A1D9-365F50DCA083Q35325312-70A85308-ABDC-4F04-AE18-80648FE6444AQ37413162-A9F999FA-7A63-4A40-8B0A-9FFC4ED1569CQ37507346-73F559D6-74FE-4C75-8B6B-A466A4DE67E7Q37700544-501B18A0-C9F8-4705-92D9-A0194295DD7EQ38067641-B765363B-A87E-4983-BBB0-BC03611C8E59Q38377860-E9942EB7-F589-4780-81A5-5F342CC0AD8CQ38636110-52CF6550-87FC-4807-B531-041011D39281Q38864796-EDFA5C51-7A85-4378-BAB7-6EC99323A32AQ48124202-6C718E6D-17AC-4686-80C3-1F99E69919E5
P2860
HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@en
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@nl
type
label
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@en
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@nl
prefLabel
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@en
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment.
@nl
P2093
P2860
P356
P1476
HLA-G1 and HLA-G5 active dimer ...... of the tumor microenvironment
@en
P2093
Béatrice Riteau
Catherine Menier
Chantal Schenowitz
Edgardo D Carosella
Favier Benoît
Nathalie Rouas-Freiss
Sonia Zilberman
Sophie Agaugué
P2860
P304
P356
10.1002/EJI.201141761
P407
P577
2012-06-01T00:00:00Z